MedPath

Randomised Trial of Intensive Behavioral Lifestyle Intervention Versus Usual Preparation for Bariatric Surgery

Not Applicable
Terminated
Conditions
Morbid Obesity
Interventions
Behavioral: Preoperative intensive behavioral lifestyle intervention
Behavioral: Preoperative usual care
Registration Number
NCT04282304
Lead Sponsor
IHU Strasbourg
Brief Summary

Prospective randomized clinical trial aiming to compare a comprehensive, intensive behavioral lifestyle intervention and usual care during the preoperative preparation to bariatric surgery, with primary outcome on excess weight loss and secondary outcomes on patient's physical status, quality of life, comorbidity and technical difficulty of the surgery.

Detailed Description

Obesity is a complex, multifactorial pathology that has major public health importance. Lifestyle modification is the cornerstone of all obesity treatments, including surgery. Throughout the non-surgical treatment options, high-intensity, on-site comprehensive lifestyle intervention has demonstrated the best efficacy in obtaining weight loss, but with a risk of progressive weight regain, after 6 months (1). In obese adults, bariatric surgery produces greater weight loss and weight loss maintenance than the conventional medical treatment and lifestyle intervention (1).

There is no consensus on whether combining these two approaches (i.e. high-intensity, on-site comprehensive lifestyle intervention and bariatric surgery) results in enhanced weight loss or more sustainable outcomes. The present randomized trial aims to answer this question.

Patients preparing for bariatric surgery will be randomized between two groups. The first group will receive the usual care as recommended by the French Health Authority ("Haute Autorité de santé"), including 6 months of endocrine and nutritional follow-up and educational intervention. The second group will receive a high-intensity, 4 weeks on-site comprehensive lifestyle intervention, including prescription of a moderately reduced-calorie diet, a program of increased physical activity, and behavioral management. The patients from both groups will then be operated on and followed for at least 2 years. Complete work-up, including clinical examination, comorbidity assessment, MRI of the liver, thigh and abdominal fat, 6 minutes' walk test, quality of life questionnaires will be performed at the begging of the follow-up, after the preparation (usual care or intensive) and 2 years after surgery. Clinical and biological assessment will be performed regularly after surgery, and technical details from the bariatric interventions will be analyzed in order to assess the eventual facilitation of the gestures in the intervention group.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • Patient with a BMI (Body Mass Index) of 40 or BMI of 35 with associated comorbidity and who desires obesity surgery
  • Patient agreeing to participate in the study, including the 2 years follow-up
  • Patient accepting the constraints of the study related to the group to which he/she will be assigned as a result of randomization (availability to his work, his family, etc.)
  • Patient able to receive and to understand the study information and to give written informed consent
  • Patient affiliated with the French social security system
Exclusion Criteria
  • Patient with a BMI of more than 60

  • Patient with contraindication to laparoscopic obesity surgery

  • Patient already operated on for obesity

  • Patient with a history of major abdominal surgery

  • Patient with contraindications to MRI:

    • pace maker or automatic defibrillator, implanted insulin pump
    • auditory neurostimulator, anal neurostimulator, etc.
    • ferromagnetic bodies in soft tissues, intraocular foreign bodies, cerebral vascular clips
    • claustrophobia
    • morphotype not allowing access to MRI: morbid obesity with waist circumference greater than 150 cm, shoulder width greater than 59 cm
  • Patient with psychiatric pathology (untreated psychosis, drug dependence, etc.)

  • Pregnant or breast-feeding patient

  • Patient in periods of exclusion (determined by a previous or ongoing study)

  • Patient under safeguard of justice

  • Patient under guardianship

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
UGECAMPreoperative intensive behavioral lifestyle interventionDuring the preoperative period, the patients in this arm will have usual care and a 4 weeks intensive, comprehensive behavioral lifestyle intervention. They will then have usual bariatric surgery and follow-up.
Usual CarePreoperative usual careThe patients in this arm will have usual care during preoperative period, bariatric surgery and follow-up.
Primary Outcome Measures
NameTimeMethod
Changes in body weightBefore preparation, before surgery, and at 1 month, 3 months, 6 months, 12 months and 24 months after surgery

Changes in body weight

Excess weight loss2 years after surgery

The percentage of excess weight loss is obtained as follow:

(initial body weight - body weight at 2 years postoperatively) / (initial body weight - ideal body weight at BMI 25) x 100

Changes in Body Mass Index (BMI)Before preparation, before surgery, and at 1 month, 3 months, 6 months, 12 months and 24 months after surgery

Changes in Body Mass Index, obtained as follow:

body weight (in kilograms)/ the square of height (in meters)

Secondary Outcome Measures
NameTimeMethod
Surgical complication assessmentUp to 24 months after surgery

percentage of patients presenting a complication

Changes in the physical status in terms of muscle/fat reportBefore preparation, before surgery and 24 months after surgery

Muscle/ Fat Cross Sectional Area report obtained by the mean of Magnetic Resonance Imaging (MRI)

Changes in the physical status in terms of waist circumferencebefore preparation, before surgery, and at 1 month, 3 months, 6 months, 12 months and 24 months after surgery

Changes in waist circumference measured in centimetres

Changes in LDL cholesterol levelsBefore preparation, before surgery and 24 months after surgery

Changes in LDL cholesterol levels (grams per liter)

Changes in the physical status in terms of walking abilitiesbefore preparation, before surgery, and at 1 month, 3 months, 6 months, 12 months and 24 months after surgery

Changes in 6-min walk test: the distance (in meters) that the patient is able to walk in 6 minutes

Changes in physical status in terms of hip circumferencebefore preparation, before surgery, and at 1 month, 3 months, 6 months, 12 months and 24 months after surgery

Changes in hip circumference measured in centimetres

Comparison of surgical difficulty in terms of postoperative hospitalisation durationAt time of surgery

Duration of the hospitalisation stay after the surgery, in days, for each group

Changes in the quality of life by the mean of the Gastrointestinal Quality of Life Index (GIQLI)before preparation, before surgery, and at 1 month, 3 months, 6 months, 12 months and 24 months after surgery

The GIQLI (Gastrointestinal Quality of Life Index) questionnaire is a digestive quality of life score including 36 items dealing with symptoms, physical status, emotions, social problems, and the effect of medical treatment in relation with gastro-intestinal disorders or procedures. The score is between 0 and 144, the higher the score, the better the quality of life.

Changes in the quality of life by the mean of a quality of life questionnaire specialized in bariatric surgerybefore preparation, before surgery, and at 1 month, 3 months, 6 months, 12 months and 24 months after surgery

"Moorehead-Ardelt Quality of Life Questionnaire II" (M-A-QoLQII) was originally designed as a disease-specific instrument to measure postoperative outcomes of self-perceived QoL in obese patients. Six areas are examined: self-esteem, physical well-being, social relationships, work, sexuality, and eating behavior. Each item is evaluated on a 10-point scale and scored from -0.5 to +0.5. The higher the score, the better the quality of life.

Changes in iron overload in the liverBefore preparation, before surgery and 24 months after surgery

The iron overload in the liver is assessed through Magnetic Resonance Imaging (MRI) measurement of the tissue relaxivity in T2 phase

Changes in surgical difficulty in terms of left liver volumeBefore preparation, before surgery and 24 months after surgery

Left liver volume, as measured by Magnetic Resonance Imaging (MRI)

Changes in surgical difficulty in terms of visceral flat volumeBefore preparation, before surgery and 24 months after surgery

Visceral Fat volume, as measured by Magnetic Resonance Imaging (MRI) on a 1 cm slide at L2-L3 level

Comparison of surgical difficulty in terms of surgery durationAt time of surgery

Total duration of Surgery, in minutes, for each group

Comparison of surgical difficulty in terms of gastric pouch positioning durationAt time of surgery

Time from trocar positioning to fashioning the gastric pouch, in minutes, for each group

Changes in the remission rate of fatty liverBefore preparation, before surgery and 24 months after surgery

the remission rate of the fatty liver is assessed by MRI (Magnetic Resonance Imaging) which provides measurements of the liver fatty infiltration

Changes in liver elasticityBefore preparation, before surgery and 24 months after surgery

The liver elasticity is assessed by Magnetic Resonance Elastography (MRE) which provides quantitative maps of its stiffness

Changes in insulin resistanceBefore preparation, before surgery and 24 months after surgery

Changes in Homeostatic Model Assessment of Insulin Resistance(HOMA-IR) levels is calculated as follow:

HOMA - IR = Insulin x Glucose / 22.5

Trial Locations

Locations (1)

Service de Chirurgie Digestive et Endocrinienne, NHC

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath